Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals
NASDAQ SPPI
$6.61 + 0.07
Day High: 6.68
Day Low: 6.54
Volume: 521,322
Provided by eSignal.
4:00 PM ET on Mar 24, 2017
Home > Investor Relations

Corporate Profile

Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncology and Hematology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System.

Ticker Symbol: SPPI

Recent Releases

ROLONTIS™ (eflapegrastim) pivotal program is on track for Spectrum to file BLA next
HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnolo
HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnolo

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Contact IR

Shareholder Tools

Search IR